Skip to main content

ADVERTISEMENT

Kristina Woodworth

08/15/2012
The use of dual-chamber implantable cardioverter-defibrillators (ICDs) to prevent sudden death in patients without an indication for permanent pacing varies widely by region and hospital, according to the results of a cross-sectional study....
The use of dual-chamber implantable cardioverter-defibrillators (ICDs) to prevent sudden death in patients without an indication for permanent pacing varies widely by region and hospital, according to the results of a cross-sectional study....
The use of dual-chamber...
08/15/2012
First Report Managed Care
11/29/2011
The biosimilars market is a growing field of competition to branded therapeutic proteins and other biologic products.
The biosimilars market is a growing field of competition to branded therapeutic proteins and other biologic products.
The biosimilars market is a...
11/29/2011
First Report Managed Care
Tools
05/25/2012
San Francisco – Researchers from Teva Pharmaceuticals have developed a web-based Safety Monitoring and Reported Tolerability Issues Index (SMARTI-I) system to help identify safety and tolerability issues, especially during formulary decision...
San Francisco – Researchers from Teva Pharmaceuticals have developed a web-based Safety Monitoring and Reported Tolerability Issues Index (SMARTI-I) system to help identify safety and tolerability issues, especially during formulary decision...
San Francisco – Researchers from...
05/25/2012
First Report Managed Care
08/15/2012
A recent study demonstrated no significant difference in time to ischemic stroke, intracerebral hemorrhage, or death from any cause in patients with reduced left ventricular ejection fraction (LVEF) and sinus rhythm who were treated with...
A recent study demonstrated no significant difference in time to ischemic stroke, intracerebral hemorrhage, or death from any cause in patients with reduced left ventricular ejection fraction (LVEF) and sinus rhythm who were treated with...
A recent study demonstrated no...
08/15/2012
First Report Managed Care
Feature
06/28/2010
Pneumococcal vaccination does not reduce the risk of acute myocardial infarction or stroke in men ≥45 years of age, according to a study published in the Journal of the American Medical Association.  
Pneumococcal vaccination does not reduce the risk of acute myocardial infarction or stroke in men ≥45 years of age, according to a study published in the Journal of the American Medical Association.  
Pneumococcal vaccination does...
06/28/2010
First Report Managed Care
07/23/2012
An analysis of data from the National Health and Nutrition Examination Survey (NHANES) has concluded that smoking, blood pressure, blood glucose level, diet, and physical activity are all closely linked with all-cause, cardiovascular disease...
An analysis of data from the National Health and Nutrition Examination Survey (NHANES) has concluded that smoking, blood pressure, blood glucose level, diet, and physical activity are all closely linked with all-cause, cardiovascular disease...
An analysis of data from the...
07/23/2012
First Report Managed Care
Feature
03/21/2011
A placebo-controlled study has found that eplerenone, a selective mineralocorticoid-receptor antagonist, reduced the risk of both cardiovascular-related death and heart failure hospitalizations in patients with chronic systolic heart failure...
A placebo-controlled study has found that eplerenone, a selective mineralocorticoid-receptor antagonist, reduced the risk of both cardiovascular-related death and heart failure hospitalizations in patients with chronic systolic heart failure...
A placebo-controlled study has...
03/21/2011
First Report Managed Care
05/24/2012
San Francisco—In a Managed Care Essentials session titled Specialty Pharmacy Challenges at the AMCP meeting, industry representatives led a discussion of current issues faced by the specialty pharmacy market.
San Francisco—In a Managed Care Essentials session titled Specialty Pharmacy Challenges at the AMCP meeting, industry representatives led a discussion of current issues faced by the specialty pharmacy market.
San Francisco—In a Managed Care...
05/24/2012
First Report Managed Care
Feature
06/21/2011
A prospective, double-blind, randomized controlled study published in the March 3, 2011, issue of the New England Journal of Medicine [2011;364(9):797-805] found no differences in patients’ global assessment of symptoms or renal function with...
A prospective, double-blind, randomized controlled study published in the March 3, 2011, issue of the New England Journal of Medicine [2011;364(9):797-805] found no differences in patients’ global assessment of symptoms or renal function with...
A prospective, double-blind,...
06/21/2011
First Report Managed Care
04/23/2012
A systematic review of the available literature has revealed that patients undergoing total or partial hip or knee arthroplasty may be at risk for venous thromboembolism (VTE) events, including deep vein thrombosis (DVT) or pulmonary embolism...
A systematic review of the available literature has revealed that patients undergoing total or partial hip or knee arthroplasty may be at risk for venous thromboembolism (VTE) events, including deep vein thrombosis (DVT) or pulmonary embolism...
A systematic review of the...
04/23/2012
First Report Managed Care